The book begins by introducing the fundamental principles and design of biosensors, including the critical role of enzymes, antibodies, and nucleic acids in target molecule recognition. It then progresses to discuss how biological interactions are translated into measurable signals. Highlighting the evolution of biosensors from early enzyme-based models to today's nanomaterial-enhanced devices, the book emphasizes the potential for personalized medicine and proactive healthcare management. It also considers the ethical and social implications of these technologies.
The book progresses through chapters that delve into specific applications like glucose monitoring, cardiac marker detection, and cancer biomarker detection. It concludes by addressing the challenges and opportunities facing the future of biosensor technology, such as improving biocompatibility and cost-effectiveness. This book uniquely focuses on the practical aspects of bringing biosensor technology from the lab to clinical use, addressing validation, regulation, and manufacturing hurdles.